Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.33 USD | -1.85% | -15.84% | +102.87% |
May. 09 | VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 14 | VTv Therapeutics Inc. Announces Board Changes | CI |
Financials (USD)
Sales 2022 | 2.02M | Sales 2023 | - | Capitalization | 23.43M |
---|---|---|---|---|---|
Net income 2022 | -19M | Net income 2023 | -20M | EV / Sales 2022 | 21.1 x |
Net cash position 2022 | 11.42M | Net cash position 2023 | 8.98M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.59
x | P/E ratio 2023 |
-1.18
x | Employees | 16 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.45% |
1 day | -1.85% | ||
1 week | -15.84% | ||
1 month | -16.38% | ||
3 months | +32.93% | ||
6 months | +63.26% | ||
Current year | +102.87% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CEO | Chief Executive Officer | 66 | 22-07-31 |
Steven Tuch
DFI | Director of Finance/CFO | 56 | 22-12-07 |
Vanessa McDade
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | Feb. 26 | |
Paul Sekhri
CEO | Chief Executive Officer | 66 | 22-07-31 |
Richard Nelson
BRD | Director/Board Member | 54 | 20-11-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 23.33 | -1.85% | 1,404 |
24-05-30 | 23.77 | +0.08% | 4,186 |
24-05-29 | 23.75 | -3.69% | 4,404 |
24-05-28 | 24.66 | -11.04% | 9,070 |
24-05-24 | 27.72 | -4.08% | 6,298 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+102.87% | 56.76M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- VTVT Stock